1 Market Overview

1.1 Product Overview and Scope of Genomics In Cancer Care

1.2 Classification of Genomics In Cancer Care by Type

1.2.1 Overview: Global Genomics In Cancer Care Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Genomics In Cancer Care Revenue Market Share by Type in 2021

1.2.3 Instruments

1.2.4 Consumables

1.2.5 Services

1.3 Global Genomics In Cancer Care Market by Application

1.3.1 Overview: Global Genomics In Cancer Care Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Diagnostics

1.3.3 Personalized Medicine

1.3.4 Drug Discovery

1.3.5 Development

1.3.6 Research

1.4 Global Genomics In Cancer Care Market Size & Forecast

1.5 Global Genomics In Cancer Care Market Size and Forecast by Region

1.5.1 Global Genomics In Cancer Care Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Genomics In Cancer Care Market Size by Region, (2017-2022)

1.5.3 North America Genomics In Cancer Care Market Size and Prospect (2017-2028)

1.5.4 Europe Genomics In Cancer Care Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Genomics In Cancer Care Market Size and Prospect (2017-2028)

1.5.6 South America Genomics In Cancer Care Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Genomics In Cancer Care Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Genomics In Cancer Care Market Drivers

1.6.2 Genomics In Cancer Care Market Restraints

1.6.3 Genomics In Cancer Care Trends Analysis

2 Company Profiles

2.1 Illumina

2.1.1 Illumina Details

2.1.2 Illumina Major Business

2.1.3 Illumina Genomics In Cancer Care Product and Solutions

2.1.4 Illumina Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Illumina Recent Developments and Future Plans

2.2 Thermo Fisher scientific

2.2.1 Thermo Fisher scientific Details

2.2.2 Thermo Fisher scientific Major Business

2.2.3 Thermo Fisher scientific Genomics In Cancer Care Product and Solutions

2.2.4 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Thermo Fisher scientific Recent Developments and Future Plans

2.3 Agilent

2.3.1 Agilent Details

2.3.2 Agilent Major Business

2.3.3 Agilent Genomics In Cancer Care Product and Solutions

2.3.4 Agilent Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Agilent Recent Developments and Future Plans

2.4 Roche

2.4.1 Roche Details

2.4.2 Roche Major Business

2.4.3 Roche Genomics In Cancer Care Product and Solutions

2.4.4 Roche Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Roche Recent Developments and Future Plans

2.5 Cancer Genetics

2.5.1 Cancer Genetics Details

2.5.2 Cancer Genetics Major Business

2.5.3 Cancer Genetics Genomics In Cancer Care Product and Solutions

2.5.4 Cancer Genetics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Cancer Genetics Recent Developments and Future Plans

2.6 Beckman Coulter

2.6.1 Beckman Coulter Details

2.6.2 Beckman Coulter Major Business

2.6.3 Beckman Coulter Genomics In Cancer Care Product and Solutions

2.6.4 Beckman Coulter Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Beckman Coulter Recent Developments and Future Plans

2.7 Bio-Rad

2.7.1 Bio-Rad Details

2.7.2 Bio-Rad Major Business

2.7.3 Bio-Rad Genomics In Cancer Care Product and Solutions

2.7.4 Bio-Rad Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Bio-Rad Recent Developments and Future Plans

2.8 Danaher

2.8.1 Danaher Details

2.8.2 Danaher Major Business

2.8.3 Danaher Genomics In Cancer Care Product and Solutions

2.8.4 Danaher Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Danaher Recent Developments and Future Plans

2.9 Sigma Aldrich

2.9.1 Sigma Aldrich Details

2.9.2 Sigma Aldrich Major Business

2.9.3 Sigma Aldrich Genomics In Cancer Care Product and Solutions

2.9.4 Sigma Aldrich Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Sigma Aldrich Recent Developments and Future Plans

2.10 Pacific Biosciences

2.10.1 Pacific Biosciences Details

2.10.2 Pacific Biosciences Major Business

2.10.3 Pacific Biosciences Genomics In Cancer Care Product and Solutions

2.10.4 Pacific Biosciences Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Pacific Biosciences Recent Developments and Future Plans

2.11 Quest Diagnostics

2.11.1 Quest Diagnostics Details

2.11.2 Quest Diagnostics Major Business

2.11.3 Quest Diagnostics Genomics In Cancer Care Product and Solutions

2.11.4 Quest Diagnostics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Quest Diagnostics Recent Developments and Future Plans

2.12 Luminex

2.12.1 Luminex Details

2.12.2 Luminex Major Business

2.12.3 Luminex Genomics In Cancer Care Product and Solutions

2.12.4 Luminex Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Luminex Recent Developments and Future Plans

2.13 Oxford Gene Technology

2.13.1 Oxford Gene Technology Details

2.13.2 Oxford Gene Technology Major Business

2.13.3 Oxford Gene Technology Genomics In Cancer Care Product and Solutions

2.13.4 Oxford Gene Technology Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Oxford Gene Technology Recent Developments and Future Plans

2.14 PerkinElmer

2.14.1 PerkinElmer Details

2.14.2 PerkinElmer Major Business

2.14.3 PerkinElmer Genomics In Cancer Care Product and Solutions

2.14.4 PerkinElmer Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 PerkinElmer Recent Developments and Future Plans

2.15 Qiagen

2.15.1 Qiagen Details

2.15.2 Qiagen Major Business

2.15.3 Qiagen Genomics In Cancer Care Product and Solutions

2.15.4 Qiagen Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Qiagen Recent Developments and Future Plans

2.16 GE Healthcare

2.16.1 GE Healthcare Details

2.16.2 GE Healthcare Major Business

2.16.3 GE Healthcare Genomics In Cancer Care Product and Solutions

2.16.4 GE Healthcare Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 GE Healthcare Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Genomics In Cancer Care Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Genomics In Cancer Care Players Market Share in 2021

3.2.2 Top 10 Genomics In Cancer Care Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Genomics In Cancer Care Players Head Office, Products and Services Provided

3.4 Genomics In Cancer Care Mergers & Acquisitions

3.5 Genomics In Cancer Care New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Genomics In Cancer Care Revenue and Market Share by Type (2017-2022)

4.2 Global Genomics In Cancer Care Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Genomics In Cancer Care Revenue Market Share by Application (2017-2022)

5.2 Global Genomics In Cancer Care Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Genomics In Cancer Care Revenue by Type (2017-2028)

6.2 North America Genomics In Cancer Care Revenue by Application (2017-2028)

6.3 North America Genomics In Cancer Care Market Size by Country

6.3.1 North America Genomics In Cancer Care Revenue by Country (2017-2028)

6.3.2 United States Genomics In Cancer Care Market Size and Forecast (2017-2028)

6.3.3 Canada Genomics In Cancer Care Market Size and Forecast (2017-2028)

6.3.4 Mexico Genomics In Cancer Care Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Genomics In Cancer Care Revenue by Type (2017-2028)

7.2 Europe Genomics In Cancer Care Revenue by Application (2017-2028)

7.3 Europe Genomics In Cancer Care Market Size by Country

7.3.1 Europe Genomics In Cancer Care Revenue by Country (2017-2028)

7.3.2 Germany Genomics In Cancer Care Market Size and Forecast (2017-2028)

7.3.3 France Genomics In Cancer Care Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Genomics In Cancer Care Market Size and Forecast (2017-2028)

7.3.5 Russia Genomics In Cancer Care Market Size and Forecast (2017-2028)

7.3.6 Italy Genomics In Cancer Care Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Genomics In Cancer Care Revenue by Type (2017-2028)

8.2 Asia-Pacific Genomics In Cancer Care Revenue by Application (2017-2028)

8.3 Asia-Pacific Genomics In Cancer Care Market Size by Region

8.3.1 Asia-Pacific Genomics In Cancer Care Revenue by Region (2017-2028)

8.3.2 China Genomics In Cancer Care Market Size and Forecast (2017-2028)

8.3.3 Japan Genomics In Cancer Care Market Size and Forecast (2017-2028)

8.3.4 South Korea Genomics In Cancer Care Market Size and Forecast (2017-2028)

8.3.5 India Genomics In Cancer Care Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Genomics In Cancer Care Market Size and Forecast (2017-2028)

8.3.7 Australia Genomics In Cancer Care Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Genomics In Cancer Care Revenue by Type (2017-2028)

9.2 South America Genomics In Cancer Care Revenue by Application (2017-2028)

9.3 South America Genomics In Cancer Care Market Size by Country

9.3.1 South America Genomics In Cancer Care Revenue by Country (2017-2028)

9.3.2 Brazil Genomics In Cancer Care Market Size and Forecast (2017-2028)

9.3.3 Argentina Genomics In Cancer Care Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Genomics In Cancer Care Revenue by Type (2017-2028)

10.2 Middle East & Africa Genomics In Cancer Care Revenue by Application (2017-2028)

10.3 Middle East & Africa Genomics In Cancer Care Market Size by Country

10.3.1 Middle East & Africa Genomics In Cancer Care Revenue by Country (2017-2028)

10.3.2 Turkey Genomics In Cancer Care Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Genomics In Cancer Care Market Size and Forecast (2017-2028)

10.3.4 UAE Genomics In Cancer Care Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Genomics In Cancer Care Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Genomics In Cancer Care Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Genomics In Cancer Care Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Genomics In Cancer Care Revenue (USD Million) by Region (2017-2022)

Table 5. Global Genomics In Cancer Care Revenue Market Share by Region (2023-2028)

Table 6. Illumina Corporate Information, Head Office, and Major Competitors

Table 7. Illumina Major Business

Table 8. Illumina Genomics In Cancer Care Product and Solutions

Table 9. Illumina Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Thermo Fisher scientific Corporate Information, Head Office, and Major Competitors

Table 11. Thermo Fisher scientific Major Business

Table 12. Thermo Fisher scientific Genomics In Cancer Care Product and Solutions

Table 13. Thermo Fisher scientific Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Agilent Corporate Information, Head Office, and Major Competitors

Table 15. Agilent Major Business

Table 16. Agilent Genomics In Cancer Care Product and Solutions

Table 17. Agilent Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Roche Corporate Information, Head Office, and Major Competitors

Table 19. Roche Major Business

Table 20. Roche Genomics In Cancer Care Product and Solutions

Table 21. Roche Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Cancer Genetics Corporate Information, Head Office, and Major Competitors

Table 23. Cancer Genetics Major Business

Table 24. Cancer Genetics Genomics In Cancer Care Product and Solutions

Table 25. Cancer Genetics Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Beckman Coulter Corporate Information, Head Office, and Major Competitors

Table 27. Beckman Coulter Major Business

Table 28. Beckman Coulter Genomics In Cancer Care Product and Solutions

Table 29. Beckman Coulter Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Bio-Rad Corporate Information, Head Office, and Major Competitors

Table 31. Bio-Rad Major Business

Table 32. Bio-Rad Genomics In Cancer Care Product and Solutions

Table 33. Bio-Rad Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Danaher Corporate Information, Head Office, and Major Competitors

Table 35. Danaher Major Business

Table 36. Danaher Genomics In Cancer Care Product and Solutions

Table 37. Danaher Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Sigma Aldrich Corporate Information, Head Office, and Major Competitors

Table 39. Sigma Aldrich Major Business

Table 40. Sigma Aldrich Genomics In Cancer Care Product and Solutions

Table 41. Sigma Aldrich Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Pacific Biosciences Corporate Information, Head Office, and Major Competitors

Table 43. Pacific Biosciences Major Business

Table 44. Pacific Biosciences Genomics In Cancer Care Product and Solutions

Table 45. Pacific Biosciences Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Quest Diagnostics Corporate Information, Head Office, and Major Competitors

Table 47. Quest Diagnostics Major Business

Table 48. Quest Diagnostics Genomics In Cancer Care Product and Solutions

Table 49. Quest Diagnostics Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Luminex Corporate Information, Head Office, and Major Competitors

Table 51. Luminex Major Business

Table 52. Luminex Genomics In Cancer Care Product and Solutions

Table 53. Luminex Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Oxford Gene Technology Corporate Information, Head Office, and Major Competitors

Table 55. Oxford Gene Technology Major Business

Table 56. Oxford Gene Technology Genomics In Cancer Care Product and Solutions

Table 57. Oxford Gene Technology Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. PerkinElmer Corporate Information, Head Office, and Major Competitors

Table 59. PerkinElmer Major Business

Table 60. PerkinElmer Genomics In Cancer Care Product and Solutions

Table 61. PerkinElmer Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Qiagen Corporate Information, Head Office, and Major Competitors

Table 63. Qiagen Major Business

Table 64. Qiagen Genomics In Cancer Care Product and Solutions

Table 65. Qiagen Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. GE Healthcare Corporate Information, Head Office, and Major Competitors

Table 67. GE Healthcare Major Business

Table 68. GE Healthcare Genomics In Cancer Care Product and Solutions

Table 69. GE Healthcare Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Global Genomics In Cancer Care Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 71. Global Genomics In Cancer Care Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 72. Breakdown of Genomics In Cancer Care by Company Type (Tier 1, Tier 2 and Tier 3)

Table 73. Genomics In Cancer Care Players Head Office, Products and Services Provided

Table 74. Genomics In Cancer Care Mergers & Acquisitions in the Past Five Years

Table 75. Genomics In Cancer Care New Entrants and Expansion Plans

Table 76. Global Genomics In Cancer Care Revenue (USD Million) by Type (2017-2022)

Table 77. Global Genomics In Cancer Care Revenue Share by Type (2017-2022)

Table 78. Global Genomics In Cancer Care Revenue Forecast by Type (2023-2028)

Table 79. Global Genomics In Cancer Care Revenue by Application (2017-2022)

Table 80. Global Genomics In Cancer Care Revenue Forecast by Application (2023-2028)

Table 81. North America Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)

Table 82. North America Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)

Table 83. North America Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)

Table 84. North America Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)

Table 85. North America Genomics In Cancer Care Revenue by Country (2017-2022) & (USD Million)

Table 86. North America Genomics In Cancer Care Revenue by Country (2023-2028) & (USD Million)

Table 87. Europe Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)

Table 88. Europe Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)

Table 89. Europe Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)

Table 90. Europe Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)

Table 91. Europe Genomics In Cancer Care Revenue by Country (2017-2022) & (USD Million)

Table 92. Europe Genomics In Cancer Care Revenue by Country (2023-2028) & (USD Million)

Table 93. Asia-Pacific Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)

Table 94. Asia-Pacific Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)

Table 95. Asia-Pacific Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)

Table 96. Asia-Pacific Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)

Table 97. Asia-Pacific Genomics In Cancer Care Revenue by Region (2017-2022) & (USD Million)

Table 98. Asia-Pacific Genomics In Cancer Care Revenue by Region (2023-2028) & (USD Million)

Table 99. South America Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)

Table 100. South America Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)

Table 101. South America Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)

Table 102. South America Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)

Table 103. South America Genomics In Cancer Care Revenue by Country (2017-2022) & (USD Million)

Table 104. South America Genomics In Cancer Care Revenue by Country (2023-2028) & (USD Million)

Table 105. Middle East & Africa Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)

Table 106. Middle East & Africa Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)

Table 107. Middle East & Africa Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)

Table 108. Middle East & Africa Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)

Table 109. Middle East & Africa Genomics In Cancer Care Revenue by Country (2017-2022) & (USD Million)

Table 110. Middle East & Africa Genomics In Cancer Care Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Genomics In Cancer Care Picture

Figure 2. Global Genomics In Cancer Care Revenue Market Share by Type in 2021

Figure 3. Instruments

Figure 4. Consumables

Figure 5. Services

Figure 6. Genomics In Cancer Care Revenue Market Share by Application in 2021

Figure 7. Diagnostics Picture

Figure 8. Personalized Medicine Picture

Figure 9. Drug Discovery Picture

Figure 10. Development Picture

Figure 11. Research Picture

Figure 12. Global Genomics In Cancer Care Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Genomics In Cancer Care Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Genomics In Cancer Care Revenue Market Share by Region (2017-2028)

Figure 15. Global Genomics In Cancer Care Revenue Market Share by Region in 2021

Figure 16. North America Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Genomics In Cancer Care Market Drivers

Figure 22. Genomics In Cancer Care Market Restraints

Figure 23. Genomics In Cancer Care Market Trends

Figure 24. Illumina Recent Developments and Future Plans

Figure 25. Thermo Fisher scientific Recent Developments and Future Plans

Figure 26. Agilent Recent Developments and Future Plans

Figure 27. Roche Recent Developments and Future Plans

Figure 28. Cancer Genetics Recent Developments and Future Plans

Figure 29. Beckman Coulter Recent Developments and Future Plans

Figure 30. Bio-Rad Recent Developments and Future Plans

Figure 31. Danaher Recent Developments and Future Plans

Figure 32. Sigma Aldrich Recent Developments and Future Plans

Figure 33. Pacific Biosciences Recent Developments and Future Plans

Figure 34. Quest Diagnostics Recent Developments and Future Plans

Figure 35. Luminex Recent Developments and Future Plans

Figure 36. Oxford Gene Technology Recent Developments and Future Plans

Figure 37. PerkinElmer Recent Developments and Future Plans

Figure 38. Qiagen Recent Developments and Future Plans

Figure 39. GE Healthcare Recent Developments and Future Plans

Figure 40. Global Genomics In Cancer Care Revenue Share by Players in 2021

Figure 41. Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 42. Global Top 3 Players Genomics In Cancer Care Revenue Market Share in 2021

Figure 43. Global Top 10 Players Genomics In Cancer Care Revenue Market Share in 2021

Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 45. Global Genomics In Cancer Care Revenue Share by Type in 2021

Figure 46. Global Genomics In Cancer Care Market Share Forecast by Type (2023-2028)

Figure 47. Global Genomics In Cancer Care Revenue Share by Application in 2021

Figure 48. Global Genomics In Cancer Care Market Share Forecast by Application (2023-2028)

Figure 49. North America Genomics In Cancer Care Sales Market Share by Type (2017-2028)

Figure 50. North America Genomics In Cancer Care Sales Market Share by Application (2017-2028)

Figure 51. North America Genomics In Cancer Care Revenue Market Share by Country (2017-2028)

Figure 52. United States Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Canada Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Mexico Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Europe Genomics In Cancer Care Sales Market Share by Type (2017-2028)

Figure 56. Europe Genomics In Cancer Care Sales Market Share by Application (2017-2028)

Figure 57. Europe Genomics In Cancer Care Revenue Market Share by Country (2017-2028)

Figure 58. Germany Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. France Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. United Kingdom Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Russia Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Italy Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Asia-Pacific Genomics In Cancer Care Sales Market Share by Type (2017-2028)

Figure 64. Asia-Pacific Genomics In Cancer Care Sales Market Share by Application (2017-2028)

Figure 65. Asia-Pacific Genomics In Cancer Care Revenue Market Share by Region (2017-2028)

Figure 66. China Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Japan Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South Korea Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. India Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Southeast Asia Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Australia Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South America Genomics In Cancer Care Sales Market Share by Type (2017-2028)

Figure 73. South America Genomics In Cancer Care Sales Market Share by Application (2017-2028)

Figure 74. South America Genomics In Cancer Care Revenue Market Share by Country (2017-2028)

Figure 75. Brazil Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Argentina Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Middle East and Africa Genomics In Cancer Care Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Genomics In Cancer Care Sales Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Country (2017-2028)

Figure 80. Turkey Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Saudi Arabia Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. UAE Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Methodology

Figure 84. Research Process and Data Source